Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens.

dc.contributor.author

Wulff-Burchfield, Elizabeth

dc.contributor.author

Schell, Wiley A

dc.contributor.author

Eckhardt, Allen E

dc.contributor.author

Pollack, Michael G

dc.contributor.author

Hua, Zhishan

dc.contributor.author

Rouse, Jeremy L

dc.contributor.author

Pamula, Vamsee K

dc.contributor.author

Srinivasan, Vijay

dc.contributor.author

Benton, Jonathan L

dc.contributor.author

Alexander, Barbara D

dc.contributor.author

Wilfret, David A

dc.contributor.author

Kraft, Monica

dc.contributor.author

Cairns, Charles B

dc.contributor.author

Perfect, John R

dc.contributor.author

Mitchell, Thomas G

dc.coverage.spatial

United States

dc.date.accessioned

2015-12-03T21:07:25Z

dc.date.issued

2010-05

dc.description.abstract

Rapid, accurate diagnosis of community-acquired pneumonia (CAP) due to Mycoplasma pneumoniae is compromised by low sensitivity of culture and serology. Polymerase chain reaction (PCR) has emerged as a sensitive method to detect M. pneumoniae DNA in clinical specimens. However, conventional real-time PCR is not cost-effective for routine or outpatient implementation. Here, we evaluate a novel microfluidic real-time PCR platform (Advanced Liquid Logic, Research Triangle Park, NC) that is rapid, portable, and fully automated. We enrolled patients with CAP and extracted DNA from nasopharyngeal wash (NPW) specimens using a biotinylated capture probe and streptavidin-coupled magnetic beads. Each extract was tested for M. pneumoniae-specific DNA by real-time PCR on both conventional and microfluidic platforms using Taqman probe and primers. Three of 59 (5.0%) NPWs were positive, and agreement between the methods was 98%. The microfluidic platform was equally sensitive but 3 times faster and offers an inexpensive and convenient diagnostic test for microbial DNA.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/20227222

dc.identifier

S0732-8893(09)00511-2

dc.identifier.eissn

1879-0070

dc.identifier.uri

https://hdl.handle.net/10161/11070

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

Diagn Microbiol Infect Dis

dc.relation.isversionof

10.1016/j.diagmicrobio.2009.12.020

dc.subject

Automation

dc.subject

Bacteriological Techniques

dc.subject

Community-Acquired Infections

dc.subject

Humans

dc.subject

Microfluidics

dc.subject

Molecular Diagnostic Techniques

dc.subject

Mycoplasma pneumoniae

dc.subject

Nasopharynx

dc.subject

Pneumonia, Mycoplasma

dc.subject

Point-of-Care Systems

dc.subject

Polymerase Chain Reaction

dc.subject

Sensitivity and Specificity

dc.subject

Time Factors

dc.title

Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens.

dc.type

Journal article

duke.contributor.orcid

Alexander, Barbara D|0000-0001-5868-0529

duke.contributor.orcid

Perfect, John R|0000-0002-6606-9460|0000-0003-3465-5518

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/20227222

pubs.begin-page

22

pubs.end-page

29

pubs.issue

1

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Infectious Diseases

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.organisational-group

Molecular Genetics and Microbiology

pubs.organisational-group

Pathology

pubs.organisational-group

School of Medicine

pubs.publication-status

Published

pubs.volume

67

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
DMID-67-22-10.pdf
Size:
322.67 KB
Format:
Adobe Portable Document Format
Description:
Published version